Dr Kelly Kruse, MD, MPH in Ankeny, IA - Pathology

Dr Kelly Kruse, MD, MPH is a Pathology - Forensic Pathology physician based in Ankeny, Iowa. Dr Kelly Kruse is licensed to practice in Iowa (license number MD-45172) and her current practice location is 2250 S Ankeny Blvd, Ankeny, Iowa. She can be reached at her office (for appointments etc.) via phone at (515) 725-1400.

NPI number for Dr Kelly Kruse is 1154766798 and her current mailing address is 2250 S Ankeny Blvd, Ankeny, Iowa. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1154766798.

Contact Information

	Dr Kelly Kruse, MD, MPH
	2250 S Ankeny Blvd, Ankeny, IA 50023-9093
	(515) 725-1400
	Not Available

Physician's Profile

Full Name	Dr Kelly Kruse
Gender	Female
Speciality	Pathology - Forensic Pathology
Location	2250 S Ankeny Blvd, Ankeny, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1154766798
Provider Enumeration Date: 05/09/2013
Last Update Date: 08/11/2020

Medical Identifiers

Medical identifiers for Dr Kelly Kruse such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154766798	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZF0201X	Pathology - Forensic Pathology	MD-45172 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kelly Kruse is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Kelly Kruse, MD, MPH 2250 S Ankeny Blvd, Ankeny, IA 50023-9093 Ph: () -	Dr Kelly Kruse, MD, MPH 2250 S Ankeny Blvd, Ankeny, IA 50023-9093 Ph: (515) 725-1400

News Archive

Hasty approval of beer mergers: Marin Institute warns of adverse consequences

Marin Institute, the alcohol industry watchdog, released a report today criticizing the hasty approval of two beer mergers that left 80 percent of the United States beer market in the hands of two foreign companies - MillerCoors and Anheuser-Busch InBev. Big Beer Duopoly: A Primer for Policymakers and Regulators describes the drastic shift in U.S. beer market ownership to this powerful duo of global corporations.

Isis files patent infringement lawsuit against Santaris for antisense drugs

Isis Pharmaceuticals, Inc. announced today it has filed a patent infringement lawsuit against Santaris Pharma A/S and Santaris Pharma A/S Corp. in the United States District Court of the Southern District of California.

Musculoskeletal ultrasound being increasingly used for diagnosis and management of rheumatic diseases

More rheumatologists are embracing musculoskeletal ultrasound (MSUS) to diagnose and manage rheumatic diseases. In response, the American College of Rheumatology (ACR) assembled a task force to investigate and determine best practices for use of MSUS in rheumatology practice. The resulting scenario-based recommendations, which aim to help clinicians understand when it is reasonable to integrate MSUS into their rheumatology practices, now appear online in Arthritis Care & Research.

Researchers identify different types of tuberculosis using new genetic barcode

Doctors and researchers will be able to easily identify different types of tuberculosis (TB) thanks to a new genetic barcode devised by scientists from the London School of Hygiene & Tropical Medicine.

Yeast protein in vaccines for more efficient immune response

To enhance the efficiency of vaccines, researchers at the division of chemical technology, Luleå University of Technolgy (LTU) have in co-operation with Karolinska Institute and Recopharma AB developed a strategy with the aim of directing vaccine components to critical parts of the immune system so that a more efficient immune response can be generated. The researchers have used a special type of protein produced in yeast.

Dr Kelly Kruse, MD, MPH - Pathology in Ankeny, IA